+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Clofibrate"

Fibrate Drugs Market Report 2025 - Product Thumbnail Image

Fibrate Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Clofibrate is a type of cardiovascular drug used to reduce cholesterol levels in the blood. It works by inhibiting the activity of an enzyme called lipoprotein lipase, which is responsible for breaking down fats in the blood. Clofibrate is usually prescribed to people with high cholesterol levels, as it can help reduce the risk of heart disease and stroke. It is also used to treat certain types of gallstones. Clofibrate is available in both generic and brand-name forms. Common brand names include Atromid-S, Lofibra, and Lipocamb. It is usually taken orally, either as a tablet or capsule, and is available in different strengths. The clofibrate market is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more